Editor's Note This phase 3, double-blind, randomized, placebo-controlled study led by researchers at the University of Minnesota, Minneapolis, finds that none of three medications evaluated—metformin, ivermectin, or fluvoxamine—prevented the occurrence of a primary event—hypoxemia, an emergency department (ED) visit, hospitalization, or death—associated with COVID-19. Of 1,323 patients analyzed, a primary…
Editor's Note The Food and Drug Administration on August 29 identified the recall by Intera Oncology of its Intera 3000 Hepatic Artery Infusion Pump as Class I, the most serious. The company is recalling the pumps after receiving reports from clinicians that the pumps were delivering medication faster than expected.…
Editor's Note This study led by researchers at the University of North Carolina School of Medicine, Chapel Hill, finds that nearly 72% of healthcare providers in US safety net practices experienced either mild or intense levels of moral distress during the first year of COVID-19 because of issues with patient…
Editor's Note ECRI, on August 29, announced its new guidance on “Supporting Resilience in Healthcare Workers” that was published on August 15 for its members. With a new focus on protecting healthcare workers against burnout and other behavioral health issues, new strategies for protecting and maintaining resilience have emerged, ECRI…
Editor's Note This study (CRISTAL randomized trial) from Australia finds that aspirin compared with enoxaparin resulted in significantly higher rates of venous thromboembolism (VTE) after total hip or knee arthroplasty. This cluster-randomized, crossover trial included 9,711 patients in 31 hospitals in Australia—5,675 in the aspirin group and 4,036 in the…
Editor's Note The Food and Drug Administration on August 25 identified the recall by Medtronic of its HeartWare Ventricular Assist Device (HVAD) system batteries as Class I, the most serious. Medtronic is recalling the batteries because they may experience electrical faults that cause them to unexpectedly fail. A similar recall…
Editor's Note On August 3, as directed by President Joe Biden in a briefing room release in April 2022, when he tasked the Department of Health and Human Services (HHS) “to coordinate the federal response to the long-term health effects of COVID-19,” as reported by OR Manager, HHS released a national…
Editor's Note The FBI on August 22 warned healthcare workers of ongoing fraud schemes where scammers impersonate law enforcement and government officials in an effort to extort money or steal personally identifiable information (PII), Healthcare Purchasing News August 24 reports. By researching a medical practice’s website or social media, scammers…
Editor's Note This study by researchers in South Korea analyzes a COVID-19 outbreak caused by vaccine breakthrough infections in a hospital where 91.9% of healthcare workers were vaccinated. In addition, it was mandatory that all healthcare workers and caregivers wear masks or respirators at all times except when eating. During…
Editor's Note The Association for the Advancement of Medical Instrumentation (AAMI) on August 24 announced the publication of a new standard: “ANSI/AAMI ST98:2022, Cleaning validation of health care products—Requirements for development and validation of a cleaning process for medical devices.” The new standard not only provides manufacturers with a formalized…